Biohaven Pharmaceutical Holding Company Ltd. Shareholders' Equity
Biohaven Pharmaceutical Holding Company Ltd. had Shareholders' Equity of -$800.93 million as of 2022-06-30, per its 10-Q filed 2022-08-05.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2022-08-05
- 2022-06-30: Stockholders' Equity Attributable to Parent -$800.93M.
- 2022-03-31: Stockholders' Equity Attributable to Parent -$462.29M.
- 2021-12-31: Stockholders' Equity Attributable to Parent -$739.38M.
- 2021-09-30: Stockholders' Equity Attributable to Parent -$587.98M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2022-06-30 | -$800.93M 10-Q · filed 2022-08-05 |
| 2022-03-31 | -$462.29M 10-Q · filed 2022-05-10 |
| 2021-12-31 | -$739.38M 10-Q · filed 2022-08-05 |
| 2021-09-30 | -$587.98M 10-Q · filed 2021-11-09 |
| 2021-06-30 | -$453.88M 10-Q · filed 2021-08-09 |
| 2021-03-31 | -$275.98M 10-Q · filed 2021-05-10 |
| 2020-12-31 | -$390.37M 10-K · filed 2022-02-25 |
| 2020-09-30 | -$212.38M 10-Q · filed 2020-11-09 |
| 2019-12-31 | -$7.42M 10-K · filed 2021-03-01 |
| 2018-12-31 | $150.92M 10-K · filed 2020-02-26 |
| 2017-12-31 | $131.97M 10-K · filed 2020-02-26 |
| 2017-09-30 | $156.19M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $192.85M 10-Q · filed 2017-08-14 |
| 2017-03-31 | -$53.54M 10-Q · filed 2017-06-16 |
| 2016-12-31 | -$45.03M 10-K · filed 2020-02-26 |
| 2015-12-31 | $1.09M 10-K · filed 2019-02-28 |
| 2014-12-31 | $1.51M 10-K · filed 2018-03-06 |